Hepatitis	B:C0085294
E	I:C0085294
virus	I:C0085294
in	O
donor	B:C0013018
plasma	B:C0032105
collected	O
in	O
Japan	B:C0022341
.	O

Human	B:C0086418
hepatitis	B:C0085294
E	I:C0085294
virus	I:C0085294
(	O
hepatitis	B:C0085294
E	I:C0085294
virus	I:C0085294
)	O
is	O
prevalent	B:C0243095
worldwide	I:C0243095
.	O

Iatrogenic	O
hepatitis	B:C0085294
E	I:C0085294
virus	I:C0085294
has	O
recently	O
been	O
identified	O
based	O
on	O
the	O
reports	B:C0684224
of	O
transfusion	O
-	O
transmitted	O
cases	O
.	O

The	O
detection	O
rate	O
of	O
HEV	B:C3263637
-	I:C3263637
RNA	I:C3263637
and	O
seroprevalence	B:C0600367
of	O
HEV	B:C0806349
-	I:C0806349
IgG	I:C0806349
/	O
IgM	B:C0806350
have	O
been	O
regionally	B:C0220825
evaluated	I:C0220825
in	O
Japan	B:C0022341
,	O
and	O
donor	B:C0013018
plasma	B:C0032105
collected	O
in	O
Hokkaido	B:C0454745
is	O
currently	O
screened	O
by	O
nucleic	B:C0200932
acid	I:C0200932
amplification	I:C0200932
testing	I:C0200932
.	O

However	O
,	O
the	O
detection	O
rate	O
of	O
HEV	B:C3263637
-	I:C3263637
RNA	I:C3263637
in	O
blood	B:C0005795
donors	I:C0005795
in	O
Japan	B:C0022341
outside	O
of	O
Hokkaido	B:C0454745
has	O
not	O
been	O
reported	O
.	O

A	O
total	O
of	O
620	O
140	O
qualified	O
donor	B:C0013018
plasma	B:C0444263
samples	I:C0444263
from	O
Japanese	B:C0022341
regions	I:C0022341
excluding	O
Hokkaido	B:C0454745
were	O
tested	O
for	O
HEV	B:C3263637
-	I:C3263637
RNA	I:C3263637
(	O
pools	O
of	O
50	O
or	O
500	O
)	O
between	O
2004	O
and	O
2014	O
.	O

HEV	B:C3263637
-	I:C3263637
RNA	I:C3263637
-	I:C3263637
positive	I:C3263637
plasma	B:C1292468
bags	I:C1292468
were	O
identified	O
,	O
and	O
the	O
hepatitis	B:C0085294
E	I:C0085294
virus	I:C0085294
viral	B:C1261478
load	I:C1261478
,	O
genotype	O
and	O
anti-HEV	B:C0312636
immunoglobulin	I:C0312636
(	I:C0312636
Ig	I:C0312636
)	I:C0312636
G/	I:C0312636
IgM	I:C0312636
were	O
evaluated	O
.	O

The	O
detection	O
rate	O
of	O
HEV	B:C3263637
-	I:C3263637
RNA	I:C3263637
(	O
pools	O
of	O
50	O
)	O
was	O
1/15	O
075	O
and	O
higher	O
in	O
eastern	B:C0022341
than	O
in	O
western	B:C0022341
Japan	I:C0022341
.	O

All	O
36	O
HEV	B:C3263637
-	I:C3263637
RNA	I:C3263637
-	I:C3263637
positive	I:C3263637
samples	B:C0444263
were	O
genotype	O
3	O
with	O
viral	B:C0376705
load	I:C0376705
ranging	O
from	O
<	O
1·69	O
to	O
7·22	O
log10	O
copies	O
/	O
ml	O
.	O

Our	O
detection	O
rate	O
of	O
HEV	B:C3263637
-	I:C3263637
RNA	I:C3263637
in	O
donor	B:C0013018
populations	I:C0013018
in	O
Japan	B:C0022341
outside	O
Hokkaido	B:C0454745
(	O
1/15	O
075	O
donations	B:C0005794
)	O
is	O
generally	O
lower	O
than	O
reported	O
in	O
Europe	B:C0015176
and	O
lower	O
than	O
previously	O
reported	O
for	O
Hokkaido	B:C0454745
(	O
1/8173	O
donations	B:C0005794
)	O
.	O

As	O
methods	O
varied	O
,	O
we	O
cannot	O
exclude	O
that	O
these	O
differences	O
are	O
reflective	O
of	O
differing	O
RNA	B:C0035668
detection	O
limits	O
.	O

In	O
contrast	O
to	O
Hokkaido	B:C0454745
where	O
genotype	O
4	O
has	O
been	O
reported	O
among	O
blood	B:C0005794
donations	I:C0005794
,	O
all	O
our	O
positive	B:C1446409
donations	B:C0005794
were	O
genotype	O
3	O
,	O
which	O
is	O
less	O
pathogenic	B:C3816499
.	O

